The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules
Open accessAbstract
Importance: Use of next-generation sequencing of RNA and machine learning algorithms can classify the risk of malignancy in cytologically indeterminate thyroid nodules to limit unnecessary diagnostic surgery. Objective: To measure the performance of a genomic sequencing classifier for cytologically indeterminate thyroid nodules. Design, Setting, and Participants: A blinded validation study was conducted on a set of cytologically indeterminate thyroid nodules collected by fine-needle aspiration biopsy between June 2009 and December 2010 from 49 academic and community centers in the United States. All patients underwent surgery without genomic information and were assigned a histopathology diagnosis by an expert panel blinded to all genomic information. There were 210 potentially eligible thyroid biopsy samples with Bethesda III or IV indeterminate cytopathology that constituted a cohort previously used to validate the gene expression classifier. Of these, 191 samples (91.0%) had adequate residual RNA for validation of the genomic sequencing classifier. Algorithm development and independent validation occurred between August 2016 and May 2017. Exposures: Thyroid nodule surgical histopathology diagnosis by an expert panel blinded to all genomic data. Main Outcomes and Measures: The primary end point was measurement of genomic sequencing classifier sensitivity, specificity, and negative and positive predictive values in biopsies from Bethesda III and IV nodules. The secondary end point was measurement of classifier performance in biopsies from Bethesda II, V, and VI nodules. Results: Of the 183 included patients, 142 (77.6%) were women, and the mean (range) age was 51.7 (22.0-85.0) years. The genomic sequencing classifier had a sensitivity of 91% (95% CI, 79-98) and a specificity of 68% (95% CI, 60-76). At 24% cancer prevalence, the negative predictive value was 96% (95% CI, 90-99) and the positive predictive value was 47% (95% CI, 36-58). Conclusions and Relevance: The genomic sequencing classifier demonstrates high sensitivity and accuracy for identifying benign nodules. Its 36% increase in specificity compared with the gene expression classifier potentially increases the number of patients with benign nodules who can safely avoid unnecessary diagnostic surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationHapeman, D. E. (1991) · Technometrics · doi:10.1080/00401706.1991.10484817 · Cited by 9,373
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
CLOPPER, C. J., & PEARSON, E. S. (1934) · Biometrika · doi:10.1093/biomet/26.4.404 · Cited by 5,003
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Lim, H., Devesa, S. S., Sosa, J. A., Check, D., & Kitahara, C. M. (2017) · JAMA · doi:10.1001/jama.2017.2719 · Cited by 2,159
Self-citationkernlab- An S4 Package for Kernel Methods in R
Karatzoglou, A., Smola, A., Hornik, K., & Zeileis, A. (2004) · Journal of Statistical Software · doi:10.18637/jss.v011.i09 · Cited by 1,786
Statistics Notes: Diagnostic tests 2: predictive values
Altman, D. G., & Bland, J. M. (1994) · BMJ · doi:10.1136/bmj.309.6947.102 · Cited by 1,711
Current Thyroid Cancer Trends in the United States
Davies, L., & Welch, H. G. (2014) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.1 · Cited by 1,615
Hegedüs, L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031436 · Cited by 1,502
Management of a Solitary Thyroid Nodule
Desforges, J. F., & Mazzaferri, E. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280807 · Cited by 1,412
Nikiforov, Y. E., Seethala, R. R., Tallini, G., Baloch, Z. W., Basolo, F., Thompson, L. D. R., Barletta, J. A., Wenig, B. M., Al Ghuzlan, A., Kakudo, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0386 · Cited by 1,404
Self-citationEconometric Computing with HC and HAC Covariance Matrix Estimators
Zeileis, A. (2004) · Journal of Statistical Software · doi:10.18637/jss.v011.i10 · Cited by 1,285
The Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2009) · Thyroid · doi:10.1089/thy.2009.0274 · Cited by 1,261
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Alexander, E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., Friedman, L., Kloos, R. T., LiVolsi, V. A., Mandel, S. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203208 · Cited by 1,163
Self-citationCross-validation pitfalls when selecting and assessing regression and classification models
Krstajic, D., Buturovic, L. J., Leahy, D. E., & Thomas, S. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-10 · Cited by 1,090
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L., & Baloch, Z. W. (2012) · Acta Cytologica · doi:10.1159/000339959 · Cited by 1,032
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.246280 · Cited by 984
Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination
Guth, S., Theune, U., Aberle, J., Galach, A., & Bamberger, C. M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02162.x · Cited by 978
Teutsch, S. M., Bradley, L. A., Palomaki, G. E., Haddow, J. E., Piper, M., Calonge, N., Dotson, W. D., Douglas, M. P., & Berg, A. O. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e318184137c · Cited by 680
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
Tuttle, R. M., Fagin, J. A., Minkowitz, G., Wong, R. J., Roman, B., Patel, S., Untch, B., Ganly, I., Shaha, A. R., Shah, J. P., et al. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.1442 · Cited by 484
Self-citationA Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology
Wang, C.-C. C., Friedman, L., Kennedy, G. C., Wang, H., Kebebew, E., Steward, D. L., Zeiger, M. A., Westra, W. H., Wang, Y., Khanafshar, E., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0243 · Cited by 362
Self-citationThyroid Nodule Size and Prediction of Cancer
Kamran, S. C., Marqusee, E., Kim, M. I., Frates, M. C., Ritner, J., Peters, H., Benson, C. B., Doubilet, P. M., Cibas, E. S., Barletta, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2968 · Cited by 292
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 282
A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Cibas, E. S., Baloch, Z. W., Fellegara, G., LiVolsi, V. A., Raab, S. S., Rosai, J., Diggans, J., Friedman, L., Kennedy, G. C., Kloos, R. T., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-5-201309030-00006 · Cited by 215
Self-citationThyroid Cancer Survival in the United States: Observational Data From 1973 to 2005
Davies, L., & Welch, H. G. (2010) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archoto.2010.55 · Cited by 203
Middleton, W. D., Teefey, S. A., Reading, C. C., Langer, J. E., Beland, M. D., Szabunio, M. M., & Desser, T. S. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.17613 · Cited by 193
Insights into the Management of Papillary Microcarcinoma of the Thyroid
Miyauchi, A., Ito, Y., & Oda, H. (2018) · Thyroid · doi:10.1089/thy.2017.0227 · Cited by 193
Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules
Li, H., Robinson, K. A., Anton, B., Saldanha, I. J., & Ladenson, P. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0459 · Cited by 165
Self-citationNou, E., Kwong, N., Alexander, L. K., Cibas, E. S., Marqusee, E., & Alexander, E. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3160 · Cited by 100
Jiang, X. “., Harrison, G. P., & Datto, M. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21802 · Cited by 87
Krauss, E. A., Mahon, M., Fede, J. M., & Zhang, L. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0154-sa · Cited by 66
Kloos, R. T. (2017) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/2017.26.suppl.05 · Cited by 49
Self-citationSonographic Patterns of Benign Thyroid Nodules: Verification at Our Institution
Virmani, V., & Hammond, I. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5363 · Cited by 47
Key Genetic and Epigenetic Mechanisms in Chemical Carcinogenesis
Ravegnini, G., Sammarini, G., Hrelia, P., & Angelini, S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv165 · Cited by 44
Molecular Biomarkers in Thyroid FNA Samples
Melillo, R. M., & Santoro, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3730 · Cited by 21
Singer, J. R., Hanna, J. W., Visaria, J., Gu, T., McCoy, M., & Kloos, R. T. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1166103 · Cited by 18
Self-citationRisk of Complications after Thyroidectomy and Parathyroidectomy
Meltzer, C. J., Klau, M., Gurushanthaiah, D., Titan, H., Meng, D., Radler, L., & Sundang, A. (2016) · Otolaryngology · doi:10.1177/0194599816644727 · Cited by 18
Cited by
Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00020-x · Cited by 590
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Self-citationSteward, D. L., Carty, S. E., Sippel, R. S., Yang, S. P., Sosa, J. A., Sipos, J. A., Figge, J. J., Mandel, S., Haugen, B. R., Burman, K. D., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4616 · Cited by 486
Self-citationUpdate on Fundamental Mechanisms of Thyroid Cancer
Prete, A., Borges de Souza, P., Censi, S., Muzza, M., Nucci, N., & Sponziello, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00102 · Cited by 471
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management
Durante, C., Hegedüs, L., Czarniecka, A., Paschke, R., Russ, G., Schmitt, F., Soares, P., Solymosi, T., & Papini, E. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0067 · Cited by 425
Metadata
- Authors
- Patel, K. N., Angell, T. E., Babiarz, J., Barth, N. M., Blevins, T., Duh, Q.-Y., Ghossein, R. A., Harrell, R. M., Huang, J., Kennedy, G. C., Kim, S. Y., Kloos, R. T., LiVolsi, V. A., Randolph, G. W., Sadow, P. M., Shanik, M. H., Sosa, J. A., Traweek, S. T., Walsh, P. S., Whitney, D., Yeh, M. W., & Ladenson, P. W.
- Venue
- JAMA Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 2018-09-01
- Volume
- 153
- Issue
- 9
- Pages
- 817
- ISSN
- 2168-6254 (ISSN-L)
- OpenAlex
- W2804198114
- Cited by
- 393
- References
- 39
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.